Clinical Trial

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Recruiting
View on ClinicalTrials.gov →
Summary
The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2022-01-31; most recent amendment 2025-05-05.
Status change: Not Yet Recruiting → Recruiting 2022-06-22
Trial Details
NCT Number NCT05234177
Lead Sponsor Tempus AI
Conditions Colorectal Cancer
Enrollment 300 participants
Start Date 2022-06-21
Primary Completion 2027-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2025-05-06